Valuation: Bionime Corporation

Market Cap 4.38B 137M 119M 110M 102M 194M 13.04B 197M 1.31B 511M 6.39B 513M 502M 22.15B P/E 2024
-31x
P/E 2025 -22.2x
Enterprise Value 6.96B 217M 189M 174M 162M 308M 20.7B 312M 2.08B 811M 10.14B 815M 797M 35.16B EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
53.01%
Yield 2024 *
-
Yield 2025 -
1 week-0.53%
Current month+1.98%
1 month+3.09%
3 months-19.35%
6 months+1.80%
Current year-4.71%
1 week 55.6
Extreme 55.6
57.9
1 month 49.75
Extreme 49.75
59.3
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
73.9
3 years 43.14
Extreme 43.1415
81.92
5 years 43.14
Extreme 43.1415
88.92
10 years 40
Extreme 40.0048
88.92
Manager TitleAgeSince
Chief Executive Officer - 2010-07-08
Director of Finance/CFO - 2017-11-05
Chief Tech/Sci/R&D Officer - 2018-11-06
Director TitleAgeSince
Chairman - 2003-04-13
Director/Board Member - 2007-10-16
Director/Board Member - 2013-06-27
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.53%-17.29%-20.35% 137M
+0.50%+13.13%+234.30%+364.43% 22.27B
-0.22%-2.39%-41.55%-25.61% 9.4B
-6.43%-6.36%+27.85%+24.71% 7.15B
-2.68%-3.73%-32.89% - 5.17B
-7.52%-3.35%-24.62%-34.66% 5.13B
+2.54%+8.84%+207.46%-25.79% 4.95B
0.00%+2.66%-22.29%-25.19% 4.23B
-4.73%-4.81%+73.33%+80.81% 4.1B
+0.35%+8.39%-17.16%-40.95% 2.61B
Average -1.82%+2.17%+38.71%+33.04% 6.52B
Weighted average by Cap. -1.46%+5.88%+90.80%+131.06%

Financials

2024 2025
Net sales 1.93B 60.32M 52.65M 48.49M 44.97M 85.58M 5.75B 86.76M 580M 226M 2.82B 227M 222M 9.77B 1.84B 57.35M 50.06M 46.11M 42.75M 81.37M 5.47B 82.49M 551M 214M 2.68B 215M 211M 9.29B
Net income -127M -3.97M -3.46M -3.19M -2.96M -5.63M -379M -5.71M -38.12M -14.84M -186M -14.9M -14.57M -643M -180M -5.62M -4.91M -4.52M -4.19M -7.98M -536M -8.09M -54.03M -21.03M -263M -21.12M -20.65M -911M
Net Debt 2.78B 86.84M 75.79M 69.81M 64.74M 123M 8.28B 125M 834M 325M 4.06B 326M 319M 14.07B 2.57B 80.28M 70.07M 64.54M 59.85M 114M 7.66B 115M 771M 300M 3.75B 301M 295M 13.01B
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
26-07-06 NT$56.70 0.00% 79,005
26-07-03 NT$56.70 +0.89% 113,159
26-07-02 NT$56.20 -1.75% 81,040
26-07-01 NT$57.20 +2.88% 92,320
26-06-30 NT$55.60 -2.80% 113,523

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4737 Stock